News

The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.
Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.
Biotech firm Windtree plans $520M Binance Coin bet via stock deals and credit line, pending shareholder approval amid mixed ...
After expanding into real estate and waste management in its search for new revenue opportunities to boost stock value, Warrington-based Windtree Therapeutics ...
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced two major equity financing agreements totaling up to ...